Treace Medical signals 2026 revenue target of $200M-$212M while expanding comprehensive bunion solutions
2026-02-27 14:58:21 ET
More on Treace Medical Concepts
- Treace Medical Concepts, Inc. (TMCI) Q4 2025 Earnings Call Transcript
- Treace Medical Concepts, Inc. (TMCI) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Treace Medical Concepts, Inc. (TMCI) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
- Treace Medical Concepts GAAP EPS of -$0.15 in-line, revenue of $62.5M beats by $0.63M
- Treace announces preliminary Q4 revenue between $62.1M to $62.5M
Read the full article on Seeking Alpha
For further details see:
Treace Medical signals 2026 revenue target of $200M–$212M while expanding comprehensive bunion solutionsNASDAQ: TMCI
TMCI Trading
0.95% G/L:
$1.595 Last:
336,713 Volume:
$1.62 Open:



